Iambic Raises Over $100 Million in an Oversubscribed Round to Advance Its Portfolio of AI-Discovered Therapeutics and Leading Platform Technologies
Support comes from new and existing investors, including life science, technology, growth, and sovereign wealth investorsFinancing closely follows announcements of Iambic’s clinical data for IAM1363 at the ESMO Congress and entry into a clinical collaboration…